Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Journal: Cancer
Published: August 09, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Journal: Cancers
Published: July 26, 2022
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 30, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 30, 2021
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.
Journal: Journal of clinical medicine
Published: November 10, 2020
Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care.
Journal: Journal of clinical medicine
Published: May 06, 2020
Strategies to Improve Participation of Older Adults in Cancer Research.
Journal: Journal of clinical medicine
Published: April 17, 2020
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
Journal: Clinical breast cancer
Published: May 17, 2018
Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors.
Journal: Psycho-oncology
Published: July 20, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026